Trial Profile
Phase II study of ontak (denileukin diftitox) for patients with relapsed/refractory non-Hodgkin's lymphoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Dec 2005
Price :
$35
*
At a glance
- Drugs Denileukin diftitox (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 21 Dec 2005 New trial record.